1-Propionyl-LSD, a comparatively new analog of the copyright drug LSD, is increasingly surfacing in the research community and gray marketplaces. Initially synthesized as a theoretical research tool, it’s generating interest due to its reportedly different potency compared to LSD, though preliminary human studies are currently obtainable. The dea